testolactone has been researched along with Polycystic Ovarian Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barbieri, RL; Droesch, K | 1 |
| Badger, T; Canick, J; Crowley, WF; Dunaif, A; Longcope, C | 1 |
2 other study(ies) available for testolactone and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Ovarian hyperstimulation syndrome associated with the use of the gonadotropin-releasing hormone agonist leuprolide acetate.
Topics: Adult; Estradiol; Female; Humans; Leuprolide; Ovarian Hyperstimulation Syndrome; Polycystic Ovary Syndrome; Testolactone | 1994 |
The effects of the aromatase inhibitor delta 1-testolactone on gonadotropin release and steroid metabolism in polycystic ovarian disease.
Topics: Adult; Androgens; Animals; Animals, Newborn; Aromatase Inhibitors; Estrogens; Female; Follicle Stimulating Hormone; Gonadotropins; Humans; Hypothalamus; In Vitro Techniques; Kinetics; Luteinizing Hormone; Metabolic Clearance Rate; Oxidoreductases; Polycystic Ovary Syndrome; Rats; Steroids; Testolactone | 1985 |